NEW YORK, January 25, 2016—Kantar Health, a leading global healthcare consulting and market research firm, today announced that Genevieve Bonnelye has been named Managing Director of Kantar Health France. In this role, Bonnelye will lead the development of real-world research and digital and market research services that will support the activities of healthcare companies across Europe as they seek to improve patient outcomes.
“The healthcare industry in Europe is changing rapidly, with increasing pressure on drug prices, especially for new products,” said Michel Murino, CEO, Kantar Health Europe. “This puts substantial pressure on the pharmaceutical industry to prove the value of their treatments. With a long history of working with real-world data and patient-reported outcomes, Genevieve is uniquely positioned to lead our team to help our clients make strategic decisions in a competitive environment using robust, rigorous insights from our data sources and our bespoke approaches.”
Bonnelye joined Kantar Health in 2003. She has led epidemiologic and observational studies and has deep expertise in managing primary data studies to support value dossiers. She has been widely published in peer-reviewed journals and presented at industry conferences. In her most recent role, she headed Kantar Health France’s real-world research business.
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. Kantar Health is part of Kantar, the data investment management division of WPP. For more information, please visit www.kantarhealth.com.